What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.4% in the afternoon session after investors ...

Through a trust, Dudum sold about $33.4 million worth of his company’s stock on Thursday, according to a filing with the ...

NVIDIA Corporation, Novo Nordisk A/S, Shift4 Payments Inc, Hims Hers Health Inc. Read 's Market Analysis on Investing.com ...

Hims & Hers shares fall after a report says the FTC has investigated its cancellation policies and billing practices for over ...

Hims & Hers Health ( NYSE: HIMS) shares traded lower for the second straight session on Tuesday after the telehealth firm’s ...

In separate filings, Chief Legal Officer Soleil Boughton sold 2,572 shares at a price of $51.64 apiece for $132,818, while ...

Hims & Hers Health’s second quarter results were met with a significant negative market reaction, as sales growth lagged Wall Street’s expectations despite a strong rise in non-GAAP profitability.

SAN FRANCISCO—Andrew Dudum, the Chief Executive Officer of Hims & Hers Health, Inc. (NYSE:HIMS), recently reported significant stock transactions, according to a recent SEC filing. On December 16 and ...

Find the latest Andrew Dudum news from Fast company. See related business and technology articles, photos, slideshows and videos.

ANDREW DUDUM: Yeah, you know, I think we're in this really fortunate position, Brian-- and thanks for having me on-- that we have an incredible amount of opportunity to grow.

Stay updated on Hims & Hers Health Q2 2025 earnings: subscriber growth, global expansion, & personalized care innovation.